10x Genomics, Inc. · NASDAQ:TXG
Stuelpnagel John R sold 20,000 10x Genomics, Inc. shares (Form 4)
Traded Sep 3, 2026 · Filed Sep 8, 2026
On Sep 3, 2026, Stuelpnagel John R (Director) sold 20,000 10x Genomics, Inc. shares at an average US$61.76 for US$1.24M, leaving 328,436 shares. Filed Sep 8, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$61.76 average (US$60.66 to US$62.61)
- Value
- US$1.24M
- Holding after
- 328,436 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Class A Common Stock | Sale | 7,012 | US$60.66 | 341,424 | Direct |
| Sep 3, 2026 | Class A Common Stock | Sale | 6,814 | US$62.11 | 334,610 | Direct |
| Sep 3, 2026 | Class A Common Stock | Sale | 6,174 | US$62.61 | 328,436 | Direct |
Source
Related
- 10x Genomics, Inc.
- Stuelpnagel John R
- 10x Genomics, Inc. shareholders
- Form 4 · Stuelpnagel John R · Aug 13, 2026
- Form 4 · Stuelpnagel John R · Jun 8, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026